Virological Efficacy and Safety of Etravirine Plus 2 Active Nucleos(t)Ide Reverse-transcriptase Inhibitors (NRTIs) in HIV-1-infected Patients.
Phase of Trial: Phase IV
Latest Information Update: 11 Mar 2018
At a glance
- Drugs Etravirine (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV-1 infections
- Focus Therapeutic Use
- 22 Sep 2011 New trial record